SANUWAVE Health, Inc.
NASDAQ:SNWVMedical - Devices
+$0.18 today
- Market cap
- $51.01M
- Beta
- 1.34
- P/E (TTM)
- 5.0
- EPS (TTM)
- $1.87
Volume 0.04M
Average 0.11M
SNWV Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
SANUWAVE Health, Inc.NASDAQ: SNWV
Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026
Net change in cash declines year over year
Q1 FY2026 net change in cash of $1.18M (cash outflow) fell 32.0% year over year, ahead of the -59.1% change in trailing-twelve-month net change in cash. Over 3 fiscal years it compounded at +47.7% a year.
Context
- Net change in cash amounted to 3.9% of revenue in FY2025, down 22.0 pp from a year earlier.
- Net change in cash increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -32.0% holds above the trailing-twelve-month pace of -59.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- 1.72M USD
- Year-over-year change
- -79.6%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.72M | -79.6% |
| FY2024 | 2024-12-31 | 8.44M | +1210.6% |
| FY2023 | 2023-12-31 | 644K | +20.6% |
| FY2022 | 2022-12-31 | 534K | +129.4% |
| FY2021 | 2021-12-31 | (1.82M) | — |
Net Change in Cash vs competitors
How SNWV compares with its peers on the latest reported figures
- SNWV's LTM Mar 2026 net change in cash of $2.28M is the smallest of the 11 companies compared; the peer median is $10.71M.
- Its year-over-year change of -59.1% is the 7th highest of 11, against a peer median of -13.4%.
- Net change in cash amounts to 5.1% of revenue for SNWV, versus a peer median of 29.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $44.87M | -202.5% | -14.0% | 38.2% | |
| LTM Mar 2026 | $40.32M | -229.0% | -23.2% | 27.8% | |
| LTM Mar 2026 | $28.13M | -286.4% | -36.5% | 8.0% | |
| LTM Mar 2026 | $27.89M | +253.0% | — | 98.8% | |
| LTM Mar 2026 | $23.54M | +27.1% | -28.1% | 29.6% | |
| LTM Mar 2026 | $11.71M | -54.0% | — | 20.3% | |
| LTM Mar 2026 | $11.46M | +137.7% | — | — | |
| LTM Dec 2025 | $9.85M | +157.7% | — | 75.6% | |
| LTM Mar 2026 | $9.7M | -81.1% | — | 23.8% | |
| LTM Mar 2026 | $3.29M | +229.9% | +20.5% | 34.3% | |
| LTM Mar 2026 | $2.28M | -59.1% | +47.7% | 5.1% | |
| Peer median (excluding SNWV) | $10.71M | -13.4% | -23.2% | 29.6% | |
Competitors are the stored peer set for SNWV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (27.26M) | (10.29M) | (25.81M) | (31.37M) | 11.81M |
| Depreciation & Amortization | 1.24M | 952K | 1.03M | 1.15M | 1.28M |
| Deferred Income Tax | 28K | 2K | 4K | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 1.51M | 0 |
| Change in Working Capital | 9.93M | (1.12M) | (3.61M) | (2.9M) | (4.01M) |
| Accounts Receivables | (395K) | (1.75M) | (53K) | (486K) | (2.3M) |
| Inventory | 1.69M | (72K) | (2.8M) | (1.2M) | (2.28M) |
| Accounts Payables | 3.18M | (2.55M) | 1.55M | (1.42M) | (521K) |
| Other Working Capital | 5.46M | 3.25M | (2.3M) | 203K | 1.09M |
| Other Non-Cash Items | 9.66M | (6.71M) | 23.84M | 34.07M | (5.21M) |
| Operating Cash Flow | (6.41M) | (17.17M) | (4.54M) | 2.46M | 3.88M |
| Capital Expenditures | (529K) | 1.02M | 0 | (490K) | (1.94M) |
| Acquisitions (Net) | 0 | 332K | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | (1.02M) | 21K | 0 | 5.38M |
| Investing Cash Flow | (529K) | 332K | 21K | (490K) | 3.43M |
| Debt Repayment | 3.38M | 16.59M | 5.85M | (2.46M) | (6.14M) |
| Common Stock Issued | 0 | 100K | 0 | 10.3M | 556K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.74M | 695K | (639K) | (1.49M) | 0 |
| Financing Cash Flow | 5.12M | 17.38M | 5.21M | 6.35M | (5.59M) |
| Effect of Forex Changes | (1K) | (13K) | (50K) | 121K | 0 |
| Net Change in Cash | (1.82M) | 534K | 644K | 8.44M | 1.72M |
| Free Cash Flow | (6.94M) | (16.15M) | (4.54M) | 1.97M | 1.93M |
SANUWAVE Health, Inc.
NASDAQ:SNWV
Intrinsic Alpha fair value
Locked
Current Price
$5.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.